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the University of São Paulo and HPV Institute, School of Medicine, Santa Casa de São Paulo, BrazilAbstractHuman papillomavirus (HPV) infections are associated with the development of anogenital lesions in men. There are no reports describing the
distribution of non-α HPV types in the anal canal of a sexually diverse group of men. The HPV Infection in Men (HIM) Study is a multicentre
study on the natural history of HPV infection in Brazil, Mexico, and the USA. At baseline, 12% of anal canal PCR HPV-positive specimens were
not typed by the Roche Linear Array, and were considered to be unclassiﬁed. Our goals were to characterize HPVs among these unclassiﬁed
specimens at baseline, and to assess associations with participant socio-demographic and behavioural characteristics. Unclassiﬁed HPVs were
typed by sequencing of ampliﬁed PGMY09/11 products or cloning of PGMY/GP + nested amplicons followed by sequencing. Further analysis
was conducted with FAP primers. Of men with unclassiﬁed HPV in the anal canal, most (89.1%) were men who have sex with women.
Readable sequences were produced for 62.8% of unclassiﬁed specimens, of which 75.2% were characterized HPV types. Eighteen, 26 and
three different α-HPV, β-HPV and γ-HPV types were detected, respectively. α-HPVs were more commonly detected among young men
(18–30 years) than among older men (45–70 years), whereas β-HPVs were more frequent among mid-adult men (31–44 years). β-HPVs
were more common among heterosexual men (85.0%) than among non-heterosexual men. All β-HPVs detected among non-heterosexual
men were β2-HPV types. The high prevalence of β-HPV in the anal canal of men who do not report receptive anal sex is suggestive of
other forms of transmission that do not involve penile–anal intercourse.
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p://dx.doi.org/10.1016/j.cmi.2014.12.023papillomavirus (HPV) causes most cases of anal cancers
(80–90%), and HPV-16 is the most prevalent type in these
tumours (~80%) [2]. Among men, the incidence of HPV-
associated anal cancer is highest in men who have sex with
men (MSM) and in human immunodeﬁciency virus (HIV)-
infected males [3].
The HPV genome consists of a circular double-stranded DNA
molecule of ~8000 bp. HPV types differ by10% in the complete
L1 gene sequence [4]. To date, 199 different HPV types have been
fully sequenced, and nearly all cluster into three genera: α-HPV,
β-HPV, and γ-HPV. Whereas α-HPVs have been mainly isolatedious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Sichero et al. HPV in the anal canal of men 503from mucosal and genital lesions, and are thus categorized as
mucosal types, β-HPVs and γ-HPVs have been mostly isolated
from the skin, and have been grouped together as cutaneousHPV
[4]. The β-HPV and γ-HPV genera have more genotypes than the
α-HPV genus, and partial DNA sequence information points to
the existence of hundreds of putative novel HPV types of both
viral genera [5,6]. Recent data indicate a high prevalence of
cutaneous HPV at diverse anatomical sites that are different from
those from which they were isolated [7–11].
The HPV Infection in Men (HIM) Study is an ongoing, pro-
spective anogenital HPV natural history study of >4000 men
aged 18–70 years residing in Brazil, Mexico, and the USA. The
baseline anal canal genotype-speciﬁc HPV prevalence in this
population was 16.3%; another 12.4% of specimens were pos-
itive for HPV DNA, but could not be classiﬁed as any of the 37
genotypes identiﬁed by the Roche Linear Array, and were
grouped as unclassiﬁed HPV [12]. Our aims were to charac-
terize HPV types among anal canal unclassiﬁed HPV specimens
collected at baseline, and to evaluate associated socio-
demographic and behavioural risk factors.Materials and methodsClinical samples and study design
Men were enrolled in Brazil (São Paulo), Mexico (Cuernavaca)
and the USA (Tampa) between 2005 and 2009, reported no
prior diagnosis of anogenital warts or cancers, and had no
recent symptoms of or treatment for a sexually transmitted
infection, including HIV/AIDS. Men completed a pre-enrolment
(baseline) visit, and were enrolled on completion of their sec-
ond (enrolment) visit 2 weeks post-baseline; they were then
followed up every 6 months for up to 4 years. Details of the
HIM Study are described elsewhere [12,13]. This cross-
sectional analysis included the 3524 men who completed
their baseline visit between September 2005 and June 2009 and
consented to collection of anal canal exfoliated cells. The ethics
committees of participating hospitals and institutions approved
all study procedures, and participants provided written
informed consent to the study protocol.
At baseline, men completed an 88-item computer-assisted
self-interview covering information about demographic char-
acteristics, substance use, and sexual behaviours. Specimens
were obtained from the genital area with Dacron swabs
(Digene, Gaithersburg, MD, USA). With a separate swab,
exfoliated cells from between the anal verge and the dentate
line were collected. All staff collecting anal canal samples were
trained to avoid touching the perianal skin with the swab. All
samples were placed in standard transport medium and stored
at –80°C until HPV testing.Clinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyHPV detection
DNA extraction was conducted with the QIAamp Media
MDx Kit (Qiagen, Valencia, CA, USA). Samples were tested
for PCR ampliﬁcation with PGMY09/11 primers, and HPV
genotyping was conducted with the Roche Linear Array
(Roche Molecular Diagnostics, Alameda, CA, USA), which is
able to discriminate 37 α-HPV types (oncogenic types 16, 18,
31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66; non-oncogenic
types 6, 11, 26, 40, 42, 53, 54, 55,61, 62, 64, 67–73, 81–84,
IS39, and CP6108) [14]. Samples that tested PCR-positive and
Linear Array-negative with all speciﬁc HPV probes were
considered to be unclassiﬁed and included in the present
study.
Unclassiﬁed HPV characterization
Puriﬁed HPV DNA was initially genotyped by direct
sequencing of PGMY09/11 PCR amplimers or cloning of these
fragments followed by sequencing. Next, 1 μL of PGMY09/11-
negative products was used in a nested PCR with GP5+/6+
primers [15]; positive samples were sequenced following
cloning. Finally, nested PCR-negative samples were subjected
to a novel ampliﬁcation reaction employing FAP59/64 primers
[16], and positive samples were analysed exclusively by direct
sequencing. AmpliTaq Gold polymerase (Perkin-Elmer,
Foster City, CA, USA) was used in all PCRs. Puriﬁcation
of the amplimers with the EXO SAP-IT (GE Healthcare, Little
Chalfont, UK) was performed before sequencing. Sequencing
was conducted in an ABI 3130XL Genetic Analyzer (AB
Applied Biosystems, Carlsbad, CA, USA) with the BigDye
Terminator v3.1 Cycle Sequencing kit (AB Applied Bio-
systems). Sequence identity was determined through com-
parison with the BlastN database.
Statistical analysis
Men were categorized as men who have sex with women
(MSW), MSM, men who have sex with both men and women,
and men who denied having any sex, based on their self-
reported recent (previous 3–6 months) and lifetime penetra-
tive sexual behaviour [17]. Specimens were classiﬁed in one of
ﬁve categories: HPV-negative, HPV-positive for a characterized
type, HPV-positive for an uncharacterized type, untyped (i.e.
inconclusive), or inadequate (human β-globin PCR-negative).
Characterized HPV types were additionally classiﬁed accord-
ing to genus and species. Differences in socio-demographic and
behavioural risk factors considered to be associated with the
presence of a speciﬁc HPV genus (α, β, or γ) and species (β1 or
β2) were evaluated with Fisher’s exact test. All statistical tests
were two-sided, and attained statistical signiﬁcance at α = 0.05.
Analyses were performed with SAS version 9.3 (SAS Institute,
Cary, NC, USA).and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 502–509
504 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIResultsA total of 4299 men attended the pre-enrolment visit of the
HIM Study from June 2005 to December 2009. Of these, 3524
men (82.0%) consented to collection of anal canal exfoliated
cells (Fig. 1). Funding restrictions allowed PCR and genotyping
on only the ﬁrst 1970 specimens collected. Three men were
eliminated because they reported HIV infection. Of the
remaining 1967 anal specimens, 1706 (86.7%) were β-globin-
positive and available for analysis. Of these 1706 valid speci-
mens, 1276 (74.8%) were negative for any HPV DNA, whereas
HPV DNA was detected by PCR or Linear Array genotyping in
the remaining 430 specimens: 213 were PCR-positive and
Linear Array-negative (unclassiﬁed specimens); 14 of these had
an insufﬁcient volume of DNA, leaving 199 available for
sequencing. Unclassiﬁed HPV specimens included 55, 71 and 73
men from the USA, Brazil, and Mexico, respectively. During
statistical analysis, one participant was excluded owing to age
inclusion criteria, leaving a total of 198 participants retained in
ﬁnal analyses. Although slight differences were observed in
participants’ characteristics by country, most men with un-
classiﬁed HPV were young (18–30 years, 37.9%) or mid-adult
(31–44 years, 40.9%); 45.0% were married, and 84.6% were
MSW (Table 1). A large proportion of men reported having hadn = 4299
n = 3524
n = 1970
n = 3
n = 1276
n = 213
n = 14
n = 1706
PCR-p
HPV-negative
FIG. 1. Diagram showing the selection of specimens from the HPV Infection
group of samples subjected to human papillomavirus (HPV) detection and typ
probe. HIV, human immunodeﬁciency virus.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectsexual intercourse with three to nine lifetime female sexual
partners (42.8%).
For unclassiﬁed HPV characterization, a broad spectrum of
viral types from the α-HPV, β-HPV and γ-HPV genera were
identiﬁed. Successful DNA sequences were obtained from 125
(62.8%) samples; 31 (24.8%) were considered to be uncharac-
terized once sequence comparison analysis indicated elevated
identity to partial HPV nucleotide sequences in GenBank,
although no type designation has yet been made. We were able
to successfully type 94 (75.2%) of the 125 sequenced speci-
mens: 26 (27.7%), 63 (67.0%) and ﬁve (5.3%) belonged to the
α-HPV, β-HPV and γ-HPV genera, respectively (Table 2). The
most common α-HPV types were HPV-74 (4.3%) and HPV-13
(3.2%), the most common β-HPV types were HPV-22 (9.6%),
HPV-107 and HPV-120 (7.4% each), and the most common
γ-HPV types were HPV-147 and HPV-130 (2.1% each) (Fig. 2).
Some differences in HPV type-speciﬁc distribution were
observed across countries. For example, γ-HPVs were not
detected in specimens from the USA, HPV-13 was only
detected in Mexico, and HPV-74 was not detected in Mexico.
Overall, 25 specimens (12.6%) were considered to be
inadequate because of non-ampliﬁcation of the human β-globin
gene, indicating that the DNA extracted was insufﬁcient or
degraded (Table 2). Furthermore, 17 (8.6%) were HPV-negative
with all primers, suggesting spurious ampliﬁcation during then = 217
n = 199
n = 261
ositive
in Men (HIM) Study pre-enrolment visit included in this analysis. *First
ing. **A positive PCR sample that did not hybridize to any speciﬁc HPV
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 502–509
TABLE 1. Characteristics of HPV Infection in Men Study participants with unclassiﬁed human papillomavirus DNA in the anal canal
Characteristic USA (n [ 55), n (%) Brazil (n [ 70), n (%) Mexico (n [ 73), n (%) Total (n [ 198), n (%) pa
Age (years) 0.0031
18–30 29 (52.6) 27 (38.6) 19 (26.0) 75 (37.9)
31–44 13 (23.7) 34 (48.6) 34 (46.6) 81 (40.9)
45–70 13 (23.7) 9 (12.8) 20 (27.4) 42 (21.2)
Median 24 34 39 35
Race <0.001
White 36 (65.4) 44 (65.7) 0 (0.0) 80 (40.4)
Black 12 (21.8) 19 (28.3) 0 (0.0) 31 (15.7)
Mixed/other 7 (12.8) 4 (6.0) 73 (100.0) 84 (42.4)
Refused/missing – – – 3 (1.5)
Ethnicity <0.001
Spanish/Hispanic/Latino 4 (9.5) 25 (36.2) 70 (100.0) 99 (50.0)
Non-Hispanic 38 (90.5) 44 (63.8) 0 (0.0) 82 (41.4)
Refused/missing – – – 17 (8.6)
Marital status <0.001
Single, never married 30 (55.6) 23 (32.9) 12 (16.7) 65 (32.8)
Married 14 (25.9) 27 (38.6) 48 (66.7) 89 (45.0)
Cohabiting 2 (3.7) 12 (17.1) 10 (13.9) 24 (12.1)
Divorced/separated/widow 8 (14.8) 8 (11.4) 2 (2.7) 18 (9.1)
Refused/missing – – – 2 (1.0)
Education <0.001
<12 years 4 (7.3) 14 (20.0) 40 (54.8) 58 (29.3)
Completed 12 years 11 (20.0) 30 (42.8) 13 (17.8) 54 (27.3)
13–16 years 37 (67.3) 22 (31.4) 15 (20.6) 74 (37.4)
17 years 3 (5.4) 4 (5.7) 5 (6.8) 12 (6.1)
Sexual orientation 0.036
MSW 49 (89.1) 53 (76.8) 62 (88.6) 164 (84.6)
MSM 2 (3.6) 4 (5.8) 0 (0.0) 6 (3.1)
MSMW 0 (0.0) 8 (11.6) 3 (4.3) 11 (5.6)
No sex 4 (7.3) 4 (5.8) 5 (7.1) 13 (6.7)
Lifetime number of female partners 0.002
No sex 7 (21.9) 6 (9.2) 5 (7.2) 18 (10.9)
1–2 7 (21.9) 8 (12.3) 10 (14.5) 25 (15.0)
3–9 11 (34.3) 20 (30.8) 40 (58.0) 71 (42.8)
10–1000 7 (21.9) 31 (47.7) 14 (20.3) 52 (31.3)
Lifetime number of male anal sex partners 0.005
No sex 52 (94.5) 49 (72.1) 66 (91.7) 167 (85.7)
1–2 3 (5.5) 8 (11.8) 4 (5.5) 15 (7.7)
3–9 0 (0.0) 5 (7.3) 1 (1.4) 6 (3.1)
10–1000 0 (0.0) 6 (8.8) 1 (1.4) 7 (3.5)
MSM, men who have sex with men; MSW, men who have sex with women; MSWM, men who have sex with men and women.
ap-value obtained with Fisher’s exact test.
CMI Sichero et al. HPV in the anal canal of men 505previous PCR/Linear Array analysis. Direct sequencing of 32
(16.0%) FAP59/64 PCR-positive specimens was inconclusive,
owing to overlapping peak patterns hindering sequence analysis
and thus HPV genotyping. Data from the three centres were
combined for the remaining analyses, which included 125
specimens for which readable DNA sequences were generated.
No risk factors were signiﬁcantly associated with the
detection of a speciﬁc HPV genus or species. Nevertheless,TABLE 2. Human papillomavirus (HPV) type distribution of
previously unclassiﬁed HPV infections, by country
USA
(n [ 55)
Brazil
(n [ 71)
Mexico
(n [ 73)
Total
(n [ 199)
n % n % n % n %
Any HPV typea 21 38.2 50 70.5 54 74.0 125 62.8
Uncharacterized HPV 6 28.6 13 26.0 12 22.2 31 24.8
Characterized HPV 15 71.4 37 74.0 42 77.8 94 75.2
α-HPV 6 40.0 10 27.0 10 23.8 26 27.7
β-HPV 9 60.0 25 67.6 29 69.1 63 67.0
γ-HPV – – 2 5.4 3 4.1 5 5.3
HPV-negative 11 20.0 3 4.2 3 4.1 17 8.6
Inadequate sample 15 27.3 3 4.2 7 9.6 25 12.6
Inconclusiveb 8 14.5 15 21.1 9 12.3 32 16.0
aCharacterized and uncharacterized types.
bSequences could not be interpreted.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyα-HPVs were more commonly detected among young men
(18–30 years) than among older men (45–70 years), whereas
β-HPVs were more prevalent in mid-adult men (31–44 years)
(p 0.06) (Table 3). Additionally, as compared with α-HPVs,
β-HPVs were non-signiﬁcantly more prevalent among MSW
than among MSM (p 0.4) and among men who reported never
using condoms during vaginal sex within the past 3 months than
among those who said they always used a condom (p 0.3).
Interestingly, all β-HPVs detected among MSM and MSMW
were from the β2 species (Table 3).DiscussionRecently, the prevalence of anal β-HPV infection and the type
distribution were analysed among Slovenian MSM, of whom
17% were HIV-positive, and β-HPV was detected in 65.2% of
specimens [9]. To our knowledge, this is the ﬁrst report to
describe the distribution of cutaneous HPVs in the anal canal of
men from three countries, most of whom are MSW, and to
investigate the risk factors associated with β-HPV detection.
We analysed 199 anal canal samples obtained from the HIMand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 502–509
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FIG. 2. Human papillomavirus (HPV) type distribution by HPV genus and species (on the x-axis) among unclassiﬁed anal canal specimens of the HPV
Infection in Men (HIM) Study at baseline (n = 94).
506 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIStudy at the baseline visit that had been categorized as un-
classiﬁed HPV specimens [12]. Eighteen, 26 and three different
α-HPV, β-HPV and γ-HPV types were detected, respectively.
β-HPVs were more common among heterosexual men (85.0%)
than among non-heterosexual men.
Unreadable sequences (and thus inconclusive typing) were
generated after direct sequencing of FAP54/69 PCR products of
16% of the specimens for which overlapping peak patterns in
sequencing chromatograms were obtained, suggesting the pres-
ence of multiple HPV types. This is a common ﬁnding when these
primers are used for a broad range of β-HPVs, and it has been
shown by DNA sequencing of a number of clones or by Luminex
methodology that these, in fact, correspond to multiple in-
fections. It has been shown not only in the normal skin and
cutaneous tumours [8] but also in the oral cavity and the nasal
mucosa [7,8] that multiple detection of β-HPVs is more frequent
than that of α-HPVs. Collectively, these ﬁndings point towards
cutaneous HPVs being a commensal component of the micro-
biological ﬂora of the human skin throughout the body [18,19].
The nucleotide sequences of 31 anal canal specimens cor-
responded to incomplete FAP59/64 sequences previouslyClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectdeposited in the GenBank database (uncharacterized HPV
types). In fact, >200 different presumed new HPV types are
waiting for full genome characterization, the majority of which
cluster within the γ-HPV genus [4–6]. Some differences were
observed regarding the prevalence of individual types among
the three geographical locations. Additionally, as previously
observed for the 37 α-HPV types that can be identiﬁed with the
Linear Array, a higher diversity of β-HPV and γ-HPV genotypes
was detected in Brazil and Mexico than in the USA [20].
Overall, anal canal unclassiﬁed HPV detection at the baseline
visit was more common in young and middle-aged adults,
married men, and MSW reporting three to nine female lifetime
sexual partners. In a previous study including 222 MSW from
two US cities, the overall HPV infection rate was 24.8%, and
another 7.7% of the men had unclassiﬁed infection at anal sites
[21]. Unfortunately, risk factor analysis was restricted to men
with HPV infections that could be characterized by the Linear
Array, precluding any comparisons.
In this study, α-HPVs were more common among young
men (18–30 years), whereas middle-aged men (45–70 years)
most frequently harboured β-HPVs. Furthermore, α-HPV typesious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 502–509
TABLE 3. Prevalence of α-human papillomaviruses (HPVs) and β-HPVs among unclassiﬁed anal canal specimens at baseline, by age
and by sexual behaviour characteristics
All αa, n (%)
β-Species
All β, n (%) B1, n (%) B2, n (%) Other β, n (%)
Ageb (years)
18–30 14 (53.5) 18 (29.0) 5 (38.5) 11 (25.0) 2 (40.0)
31–44 7 (30.2) 32 (51.6) 6 (46.1) 25 (56.8) 1 (20.0)
45–70 5 (16.3) 12 (19.4) 2 (15.4) 8 (18.2) 2 (40.0)
Sexual orientation
No sex 2 (8.4) 3 (5.0) 1 (7.7) 1 (2.4) 1 (20.0)
MSW 17 (70.9) 51 (85.0) 12 (92.3) 35 (83.3) 4 (80.0)
MSM 2 (8.4) 2 (3.3) 0 (0.0) 2 (4.8) 0 (0.0)
MSMW 3 (12.3) 4 (6.7) 0 (0.0) 4 (9.5) 0 (0.0)
Lifetime number of female partners
No sex 3 (15.0) 4 (7.1) 1 (8.3) 2 (5.0) 1 (25.0)
1–2 4 (20.0) 8 (14.3) 0 (0.0) 8 (20.0) 0 (0.0)
3–9 5 (25.0) 25 (44.7) 6 (50.0) 18 (45.0) 1 (25.0)
10–1000 8 (40.0) 19 (33.9) 5 (41.7) 12 (30.0) 2 (50.0)
Number of female partners in the past 3 months
None 11 (55.0) 23 (42.6) 3 (27.3) 18 (45.0) 2 (66.7)
1 4 (20.0) 20 (35.7) 5 (45.4) 14 (35.0) 1 (33.3)
2 5 (25.0) 11 (19.7) 3 (27.3) 8 (20.0) 0 (0.0)
Lifetime number of male anal sex partners
No sex 17 (68.0) 54 (87.1) 13 (100.0) 36 (81.8) 5 (100.0)
1–2 3 (12.0) 3 (4.8) 0 (0.0) 3 (6.8) 0 (0.0)
3–9 0 (0.0) 3 (4.8) 0 (0.0) 3 (6.8) 0 (0.0)
10–1000 5 (20.0) 2 (3.3) 0 (0.0) 2 (4.6) 0 (0.0)
Number of male anal sex partners in the past 3 months
None 21 (84.0) 60 (96.8) 13 (100.0) 42 (95.4) 5 (100.0)
1 0 (0.0) 1 (1.6) 0 (0.0) 1 (2.3) 0 (0.0)
2 4 (16.0) 1 (1.6) 0 (0.0) 1 (2.3) 0 (0.0)
Condom use during vaginal sex in the past 3 months
Always 3 (15.0) 6 (10.6) 1 (8.3) 5 (12.2) 0 (0.0)
Sometimes 7 (35.0) 19 (33.3) 4 (33.3) 15 (36.6) 0 (0.0)
Never 4 (20.0) 22 (38.6) 6 (50.0) 14 (34.2) 2 (50.0)
No recent vaginal sex 6 (30.0) 10 (17.5) 1 (8.3) 7 (17.0) 2 (50.0)
Condom use during anal sex in the past 3 months
Always 3 (18.7) 7 (24.1) 2 (40.0) 5 (22.7) 0 (0.0)
Sometimes 3 (18.7) 1 (3.5) 0 (0.0) 1 (4.6) 0 (0.0)
Never 3 (18.7) 7 (24.1) 1 (20.0) 5 (22.7) 1 (50.0)
No recent anal sex 7 (43.8) 14 (48.3) 2 (40.0) 11 (50.0) 1 (50.0)
MSM, men who have sex with men; MSW, men who have sex with women; MSWM, men who have sex with men and women.
aDifferences in α-HPVs and β-HPVs, and in β1-HPVs and β2-HPVs, by exposure were assessed with Fisher’s exact test.
bAll p-values were >0.10, with the exception of age (p 0.06), which was different among men in whom we detected α-HPVs vs. β-HPVs.
CMI Sichero et al. HPV in the anal canal of men 507were more commonly detected among previously unclassiﬁed
specimens obtained from MSM and MSWM than were cuta-
neous HPV types. In fact, for this population, it has been re-
ported that the HPV infection prevalence among MSM is four to
ten times higher than that among MSW for HPVs discriminated
by the Linear Array, whereas MSW and MSM had almost the
same prevalence of unclassiﬁed HPV [12]. Although the small
sample size may explain the lack of sufﬁcient power to identify
risk factors for β-HPV infection, we cannot exclude the pos-
sibility of other unmeasured factors being associated with anal
β-HPV detection. For example, the questionnaire completed by
HIM Study participants focused mostly on penetrative sexual
practices, and did not ask questions about masturbation and
non-penetrative sexual activities. It is plausible that direct digit/
object contact may favour viral transmission of cutaneous HPV
to the anal area. In fact, evidence of hand transmission to the
anogenital region has been reported for α-HPVs [22], and
α-HPV has been detected on the ﬁngers of women infected in
the cervix [23]. The possibility remains that the detection of
β-HPVs in the anal canal may represent the deposition of vi-
rions shed from other body sites.Clinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyThis study was designed to identify HPVs that were detected
in the anal canal of men and grouped together as unclassiﬁed
HPVs at baseline. Thus, potential limitations of this study
include the exclusion of specimens for which an HPV type was
assigned by Linear Array, although these specimens may also
co-harbour β-HPVs and/or γ-HPVs. Co-detection of α-HPVs
and β-HPVs was commonly observed in the oral cavity [7] and
in penile condylomas [24].
We recently reported the broad distribution of β-HPVs and
γ-HPVs in genital specimens of men from the HIM Study
[11,25]. We also observed among these men that β-HPV DNA
is prevalent in 61.1% of external genital lesions, and that most
viral DNA is detected on the normal genital skin before
external genital lesion development [26].
Although HPVs are widely detected throughout the human
body, the role of cutaneous HPVs in the development of lesions
and skin cancer has not been determined. Some studies indicate
that skin infected with β-HPVs has increased susceptibility to
UV radiation-induced DNA damage, which may precede skin
cancer development. Currently, however, it is only accepted
that HPV-5 and HPV-8 are associated with benign and malignantand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 502–509
508 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIlesions of the cutaneous disease epidermodysplasia verruci-
formis [27]. Additionally, the mere detection of HPV DNA by
PCR in healthy skin does not necessarily correspond to active
viral infection. It has been hypothesized that true infections
should contain viral transcripts as an indication of viral activity.
Interestingly, α-HPV and β-HPV DNAs were detected in the
oral cavity, but only α-HPV transcripts were present in cancer
specimens [28].
This study provides evidence that cutaneous HPV is a
common ﬁnding in the anal canal in men. At present, it is not
known whether β-HPVs inﬂuence lesion development in the
anogenital region of men; determination of a possible role of
β-HPVs and γ-HPVs as cofactors in the oncogenesis of ano-
genital cancer may be hampered by the ubiquity of these viral
types on the skin surface. Larger studies with extended follow-
up in MSM and MSW will contribute to this knowledge, and
may help in the evaluation of strategies for prevention of anal
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